CARRIE CHESHER: Open Payments
NPI 1508267246 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,751 in 60 payments from 14 companies in 2025. Trend: 2023 $1,371 · 2024 $1,467 · 2025 $1,751
Food & beverage: $1,716Education: $35
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 14 | $351 |
| Medtronic, Inc. | 3 | $310 |
| Verity Pharmaceuticals Inc. | 11 | $277 |
| Endo USA, Inc. | 8 | $197 |
| Antares Pharma, Inc. | 7 | $175 |
| Ferring Pharmaceuticals Inc. | 4 | $91 |
| Olympus America Inc. | 4 | $87 |
| Procept Biorobotics Corporation | 2 | $81 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
Products named: GEMTESA, Trelstar, XYOSTED, INTERSTIM, ALTAVIVA, AVEED, ORGOVYX, ADSTILADRIN.
Industry payments across IN — which companies pay providers there.
